Supplementary Figure S3 from Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer

Authors :: Filippo de Braud
Maria Di Bartolomeo
Giovanni Fucà
Massimo Di Maio
Federica Di Nicolantonio
Massimo Milione
Elena Tamborini
Federica Perrone
Ludovic Barault
Marco Macagno
Antonia Martinetti
Federica Palermo
Vincenzo Guarini
Filippo Pagani
Salvatore Corallo
Giovanni Randon
Stefania Gori
Fausto Petrelli
Gabriella Farina
Raffaella Longarini
Gianluca Tomasello
Andrea Sartore-Bianchi
Sabina Murgioni
Lorenza Rimassa
Stefania Mosconi
Federica Morano
Alessandra Raimondi
Sara Lonardi
Maria Antista
Riccardo Lobefaro
Filippo Pietrantonio
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure S3. The waterfall plots of the best percentage change in the tumor burden from baseline evaluation in patients treated with CAPTEM (A) and FOLFIRI (B).

Tools